Our results with mice suggest that such selective alterations of FAT1 function/expression may matter during development, in muscle precursors, at a stage when their migration occurs, for which FSHD human material was not available so far - and can ethically not be sought. The gene discussed is FAT1; the disease is facioscapulohumeral muscular dystrophy.